CME and CFTC Clash Over On-Chain Perpetual Futures

The CME Group, the largest derivatives exchange operator in the US, is locked in a battle with its regulator, the Commodity Futures Trading Commission (CFTC), over the introduction of blockchain-based perpetual futures products. The CFTC recently approved the listing of crypto perpetual futures, also known as 'perps', on the prediction markets platform Kalshi and cryptocurrency exchange Coinbase, sparking a lawsuit from the CME. The CME claims that the CFTC is mislabeling these products and misapplying the law, as futures contracts require an end date, whereas perps are designed for traders to take a financial position on an asset's future without any deadlines. The dispute has significant implications for the US approach to the rapidly growing perps market, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CME argues that the CFTC's sudden embrace of perps did not consider the ramifications and will harm its long-dated futures products. The tension between the two entities has been escalating, with the CME attempting to fast-track 24/7 trading for crude oil futures, only to be blocked by the CFTC. The CFTC's chairman, Mike Selig, has defended the regulator's decision, stating that the CME's actions are 'wholly inappropriate'. The CME's chairman, Terry Duffy, has countered that the CFTC is not following protocol and may not be prepared to enforce its emerging perps policy properly. The dispute has sparked frustration among those supporting the CFTC's reforming agenda, with some viewing the CME's actions as an attempt to stifle innovation and competition. The future of CFTC-driven perps remains uncertain as the CME readies its case, with claims that the agency rubber-stamped the Kalshi application and failed to issue a regulation despite seeking public comment. The outcome of this legal dispute will have significant implications for the US perps market and the regulatory landscape for cryptocurrencies.